Medicine and Dentistry
Microtubule
100%
Eribulin
57%
Signal Transduction
28%
Stabilizing Agent
28%
Triple Negative Breast Cancer
28%
Therapeutic Procedure
28%
Biological Product
14%
Solid Malignant Neoplasm
14%
Cancer Cell
14%
Paclitaxel
14%
Hematologic Malignancy
14%
Cytotoxicity
14%
Antiinfective Agent
14%
Interferon
14%
Mitochondrial DNA
14%
Introspection
14%
Cell Cycle Progression
14%
Aptitude
14%
Immunology and Microbiology
Microtubule
100%
Signal Transduction
28%
Immunity
28%
Breast
28%
Biological Product
14%
Interferon Type I
14%
Solid
14%
Cell Cycle Progression
14%
Cancer Cell
14%
Cytotoxicity
14%
Myeloid
14%
Introspection
14%
Aptitude
14%
Pharmacology, Toxicology and Pharmaceutical Science
Eribulin
57%
Antimitotic Agent
28%
Triple Negative Breast Cancer
28%
Biological Product
14%
Solid Malignant Neoplasm
14%
Paclitaxel
14%
Antiinfective Agent
14%
Interferon
14%
Cellular Processes
14%
Hematologic Malignancy
14%
Mitochondrial DNA
14%
Neuroscience
Eribulin
57%
Cell Signaling
28%
Mitochondrial DNA
28%
Cell Cycle Progression
14%
Paclitaxel
14%
Interferon
14%
Cytotoxicity
14%
Myeloid
14%